New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences by longitudeadmin | Dec 9, 2013 | Portfolio News
Allergen Research Corporation Announces $17 Million Series A Financing by longitudeadmin | Nov 21, 2013 | Portfolio News
Esperion Therapeutics Presents Full Results of Phase 2 Clinical Study Demonstrating that ETC-1002 Lowered LDL-C by an Average of 32 Percent and Was Well Tolerated in Patients with Hypercholesterolemia and History of Statin Intolerance by longitudeadmin | Nov 18, 2013 | Portfolio News
Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation by longitudeadmin | Nov 14, 2013 | Portfolio News
Civitas Therapeutics Extends CVT-301 Patent Protection into 2032 by longitudeadmin | Nov 8, 2013 | Portfolio News
